Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Antaxone
2. Celupan
3. En 1639a
4. En-1639a
5. En1639a
6. Nalorex
7. Naltrexone
8. Nemexin
9. Revia
10. Trexan
1. Naltrexone Hcl
2. 16676-29-2
3. Trexan
4. Depade
5. Antaxone
6. Revia
7. Naltrexone (hydrochloride)
8. En-1639a
9. Nih 8503
10. Celupan
11. Nemexin
12. N-cyclopropylmethyl-noroxymorphone Hydrochloride
13. Mls000069607
14. Naltrexone Hydrochloride [usp]
15. Z6375yw9sf
16. Vivitrex
17. 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one Hydrochloride
18. Nalorex
19. Smr000058767
20. En-1639a (as Hydrochloride)
21. En 1639a
22. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
23. Naltrexone Hydrochloride (usp)
24. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one Hydrochloride
25. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride (1:1), (5alpha)-
26. Ccris 1168
27. Einecs 240-723-0
28. Unii-z6375yw9sf
29. Naltrel
30. Naltrexone.hcl
31. Naltrexone Depot
32. Prestwick_348
33. Mfcd00069324
34. (5alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
35. Revia (tn)
36. Xr-ntx
37. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
38. Opera_id_1828
39. Naltrexone Monohydrochloride
40. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-, Hydrochloride
41. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5-alpha)-
42. Schembl37713
43. Mls001076516
44. Mls002153483
45. Mls002695940
46. Cyto-205
47. Chembl1201149
48. Dtxsid50937236
49. Pti-901
50. Chebi:134687
51. Bcp08343
52. Naltrexone Hydrochloride [mi]
53. S2103
54. Vp-004
55. Akos015994597
56. Ccg-268383
57. Cs-0763
58. Hs-0003
59. Nc00693
60. 17-cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
61. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-oxy-3,14-dihydoxy-, Hydrochloride
62. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5alpha)-
63. Naltrexone Hydrochloride [mart.]
64. Naltrexone Hydrochloride [vandf]
65. Naltrexone Hydrochloride [who-dd]
66. Bn164635
67. Hy-76710
68. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, Hydrochloride, (5.alpha.)-
69. N1176
70. Naltrexone Hydrochloride [green Book]
71. Sw196619-3
72. Naltrexone Hydrochloride [orange Book]
73. D02095
74. Embeda Component Naltrexone Hydrochloride
75. H10489
76. Naltrexone Hydrochloride [ep Monograph]
77. Naltrexone Hydrochloride [usp Monograph]
78. Troxyca Component Naltrexone Hydrochloride
79. 676n292
80. Contrave Component Naltrexone Hydrochloride
81. Naltrexone Hydrochloride Component Of Embeda
82. Naltrexone Hydrochloride Component Of Troxyca
83. Naltrexone Hydrochloride Component Of Contrave
84. Q27096434
85. Z1558290144
86. Naltrexone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
87. Naltrexone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
88. (5a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-morphinan-6-one Hydrochloride
89. 17-(cyclopropylmethyl)-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one Hydrochloride
90. 17-cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride
91. (1s,5r,13r,17s)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one Hydrochloride
92. (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride
93. (5alpha,17r)-17-(cyclopropylmethyl)-3,14-dihydroxy-6-oxo-4,5-epoxymorphinan-17-ium Chloride
94. Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-, Hydrochloride (1:1)
Molecular Weight | 377.9 g/mol |
---|---|
Molecular Formula | C20H24ClNO4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Exact Mass | 377.1393859 g/mol |
Monoisotopic Mass | 377.1393859 g/mol |
Topological Polar Surface Area | 70 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 621 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Naltrexone hydrochloride |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | Naltrexone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced by a cyclopropylmethy... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg |
Market Status | Prescription |
Company | Accord Hlthcare; Mallinckrodt; Sun Pharma Global; Elite Labs; Barr |
2 of 6 | |
---|---|
Drug Name | Revia |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | REVIA (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva Womens |
3 of 6 | |
---|---|
Drug Name | Vivitrol |
Active Ingredient | Naltrexone |
Dosage Form | For suspension, extended release |
Route | Intramuscular |
Strength | 380mg/vial |
Market Status | Prescription |
Company | Alkermes |
4 of 6 | |
---|---|
Drug Name | Naltrexone hydrochloride |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | Naltrexone hydrochloride, an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced by a cyclopropylmethy... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 100mg; 50mg |
Market Status | Prescription |
Company | Accord Hlthcare; Mallinckrodt; Sun Pharma Global; Elite Labs; Barr |
5 of 6 | |
---|---|
Drug Name | Revia |
PubMed Health | Naltrexone |
Drug Classes | Ethanol Dependency, Opioid Dependency, Toxicology-Antidote Agent |
Drug Label | REVIA (naltrexone hydrochloride tablets USP), an opioid antagonist, is a synthetic congener of oxymorphone with no opioid agonist properties. Naltrexone differs in structure from oxymorphone in that the methyl group on the nitrogen atom is replaced... |
Active Ingredient | Naltrexone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva Womens |
6 of 6 | |
---|---|
Drug Name | Vivitrol |
Active Ingredient | Naltrexone |
Dosage Form | For suspension, extended release |
Route | Intramuscular |
Strength | 380mg/vial |
Market Status | Prescription |
Company | Alkermes |
Alcohol Deterrents
Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-17
Pay. Date : 2013-03-11
DMF Number : 20623
Submission : 2007-06-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-27
Pay. Date : 2012-11-30
DMF Number : 21590
Submission : 2008-04-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-16
Pay. Date : 2012-12-20
DMF Number : 15102
Submission : 2000-10-18
Status : Active
Type : II
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-14
Pay. Date : 2013-12-20
DMF Number : 23325
Submission : 2009-12-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21820
Submission : 2008-07-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-05
Pay. Date : 2012-11-27
DMF Number : 6265
Submission : 1986-04-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-16
Pay. Date : 2013-01-28
DMF Number : 23214
Submission : 2009-10-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-22
Pay. Date : 2021-12-03
DMF Number : 36560
Submission : 2022-03-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21217
Submission : 2007-12-28
Status : Active
Type : II
Certificate Number : CEP 2009-287 - Rev 03
Status : Valid
Issue Date : 2024-03-01
Type : Chemical
Substance Number : 1790
Certificate Number : R1-CEP 2008-058 - Rev 00
Status : Valid
Issue Date : 2014-09-12
Type : Chemical
Substance Number : 1790
Certificate Number : R1-CEP 2016-053 - Rev 00
Status : Valid
Issue Date : 2023-01-13
Type : Chemical
Substance Number : 1790
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
Naltrexone Hydrochloride, Wavelength Site
Certificate Number : CEP 2020-291 - Rev 02
Status : Valid
Issue Date : 2024-04-23
Type : Chemical
Substance Number : 1790
Certificate Number : CEP 2018-218 - Rev 02
Status : Valid
Issue Date : 2024-11-20
Type : Chemical
Substance Number : 1790
Certificate Number : R1-CEP 2006-117 - Rev 02
Status : Valid
Issue Date : 2017-05-05
Type : Chemical
Substance Number : 1790
Certificate Number : CEP 2017-313 - Rev 02
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 1790
Certificate Number : R1-CEP 2009-352 - Rev 03
Status : Valid
Issue Date : 2023-02-15
Type : Chemical
Substance Number : 1790
Certificate Number : R1-CEP 2012-047 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2021-01-08
Type : Chemical
Substance Number : 1790
Certificate Number : R0-CEP 2008-167 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2010-01-07
Type : Chemical
Substance Number : 1790
Date of Issue : 2021-08-27
Valid Till : 2024-06-10
Written Confirmation Number : WC-0278
Address of the Firm : Plot No. 6406, GIDC Estate, Ankleshwar-393002, Dist. Bharuch, Gujarat
Naltrexone Hydrochloride USP/EP
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No. 24/2, & 25, Phase -IV, GIDC, Industrial Zone, At & Post - Panoli, Dist....
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2019-05-30
Registration Number : 20190530-209-J-359
Manufacturer Name : Sanofi Winthrop Industrie
Manufacturer Address : Route d'Avignon 30390 Aramon, France
Registrant Name : Base Farm Co., Ltd.
Registration Date : 2021-09-30
Registration Number : 20210611-209-J-542(1)
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Phamchem Service Co., Ltd.
Registration Date : 2023-10-16
Registration Number : 20210611-209-J-542(2)
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Hiple Co., Ltd.
Registration Date : 2021-06-11
Registration Number : 20210611-209-J-542
Manufacturer Name : Rusan Pharma Ltd.
Manufacturer Address : Plot no. 6406, GIDC ESTATE, ANKLESHWAR, City : ANKLESHWAR - 393 002, Dist : Bharuch, ...
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2021-03-31
Registration Number : 20210331-209-J-569
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North Second Street, St, Louis, Missouri 63147, USA
Registrant Name : CTC Bio Co., Ltd.
Registration Date : 2020-09-23
Registration Number : 20200923-209-J-729
Manufacturer Name : Siegfried PharmaChemikalien ...
Manufacturer Address : Karlstraße 15-39, 42-44, 32423 Minden, Germany
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2024-10-21
Registration Number : 20241021-209-J-1705
Manufacturer Name : Sun Pharmaceutical Industrie...
Manufacturer Address : Plot No. 24/2 & 25, Phase-IV, GIDC Industrial Zone, AT & Post Panoli-394 116, Distric...
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 52465-103
Start Marketing Date : 2013-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
NDC Package Code : 50396-6008
Start Marketing Date : 2013-12-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60870-0395
Start Marketing Date : 1990-01-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-109
Start Marketing Date : 2024-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70312-0887
Start Marketing Date : 2015-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Deccan Nutraceuticals: A global leader in the integrated development, manufacturing, and marketing of pharmaceutical products.
NDC Package Code : 45085-0292
Start Marketing Date : 2024-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
NDC Package Code : 51634-1064
Start Marketing Date : 2024-01-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NALTREXONE HYDROCHLORIDE DIHYDRATE
NDC Package Code : 63275-9874
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-11-01
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0406-1479
Start Marketing Date : 2013-04-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-115
Start Marketing Date : 2024-05-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50mg
Packaging : Pack Size 3x10; 2x14; 10x10
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet Implant
Dosage Strength : 765mg
Packaging : Pack Size 2 Tablets in 1 Carton; 1 Tablets in 1 Carton
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2009-08-13
Application Number : 22321
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Naltrexone Abcur
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
Brand Name : CONTRAVE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 90MG;8MG
Packaging :
Approval Date : 2014-09-10
Application Number : 200063
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2000-03-08
Application Number : 75434
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2002-03-22
Application Number : 76264
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REVIA
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 50
Approval Date :
Application Number : 2213826
Regulatory Info : Prescription
Registration Country : Canada
RLD : No
TE Code : AB
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 2011-08-17
Application Number : 91205
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code :
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2009-08-13
Application Number : 22321
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Brand Name : EMBEDA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2009-08-13
Application Number : 22321
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 1998-05-08
Application Number : 74918
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 1999-05-26
Application Number : 75274
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 2000-03-08
Application Number : 75434
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 2002-03-22
Application Number : 76264
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code : AB
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 2002-03-22
Application Number : 76264
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : NALTREXONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Approval Date : 2002-03-22
Application Number : 76264
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
Brand Name : TROXYCA ER
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 9.6MG;80MG
Approval Date : 2016-08-19
Application Number : 207621
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Regulatory Info :
Registration Country : Sweden
Brand Name : Naltrexone Accord
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Naltrexone
Dosage Form : Naltrexone 50Mg 14 Joined' Oral Use
Dosage Strength : 14 cpr riv 50 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Naltrexone Abcur
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Opizone
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Naltrexin
Dosage Form : Filmtabl
Dosage Strength : 50mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Antaxone
Dosage Form : Naltrexone 50Mg 14 Joined' Oral Use
Dosage Strength : 14 cps 50 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Antaxone
Dosage Form : Naltrexone 50Mg 10 Units Oral Use
Dosage Strength : os soluz 10 vials 50 mg 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Naltrexone POA Pharma
Dosage Form : FILM COATED PILL
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Narcoral
Dosage Form : Naltrexone 50Mg 10 Units Oral Use
Dosage Strength : 10 CPR 50 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Revia 50Mg 28 Coated Tablets
Dosage Form : Coated Tablet
Dosage Strength : 50 Mg/Coated Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : APO-NALTREXONE
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 30/50
Approval Date :
Application Number : 2444275
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CONTRAVE
Dosage Form : TABLET (EXTENDED-RELEASE)
Dosage Strength : 8MG
Packaging : 70/120
Approval Date :
Application Number : 2472945
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NALTREXONE HYDROCHLORIDE TABLETS USP
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 28
Approval Date :
Application Number : 2451883
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REVIA
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 50
Approval Date :
Application Number : 2213826
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Naltima
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Contrave
Dosage Form : Tab
Dosage Strength : 8mg
Packaging : 112X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Naltrexone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naltrexone Hydrochloride manufacturer or Naltrexone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naltrexone Hydrochloride manufacturer or Naltrexone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Naltrexone Hydrochloride API Price utilized in the formulation of products. Naltrexone Hydrochloride API Price is not always fixed or binding as the Naltrexone Hydrochloride Price is obtained through a variety of data sources. The Naltrexone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trexan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trexan, including repackagers and relabelers. The FDA regulates Trexan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trexan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trexan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trexan supplier is an individual or a company that provides Trexan active pharmaceutical ingredient (API) or Trexan finished formulations upon request. The Trexan suppliers may include Trexan API manufacturers, exporters, distributors and traders.
click here to find a list of Trexan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trexan DMF (Drug Master File) is a document detailing the whole manufacturing process of Trexan active pharmaceutical ingredient (API) in detail. Different forms of Trexan DMFs exist exist since differing nations have different regulations, such as Trexan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trexan DMF submitted to regulatory agencies in the US is known as a USDMF. Trexan USDMF includes data on Trexan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trexan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trexan suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trexan Drug Master File in Korea (Trexan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trexan. The MFDS reviews the Trexan KDMF as part of the drug registration process and uses the information provided in the Trexan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trexan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trexan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trexan suppliers with KDMF on PharmaCompass.
A Trexan CEP of the European Pharmacopoeia monograph is often referred to as a Trexan Certificate of Suitability (COS). The purpose of a Trexan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trexan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trexan to their clients by showing that a Trexan CEP has been issued for it. The manufacturer submits a Trexan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trexan CEP holder for the record. Additionally, the data presented in the Trexan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trexan DMF.
A Trexan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trexan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trexan suppliers with CEP (COS) on PharmaCompass.
A Trexan written confirmation (Trexan WC) is an official document issued by a regulatory agency to a Trexan manufacturer, verifying that the manufacturing facility of a Trexan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trexan APIs or Trexan finished pharmaceutical products to another nation, regulatory agencies frequently require a Trexan WC (written confirmation) as part of the regulatory process.
click here to find a list of Trexan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trexan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trexan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trexan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trexan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trexan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trexan suppliers with NDC on PharmaCompass.
Trexan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trexan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trexan GMP manufacturer or Trexan GMP API supplier for your needs.
A Trexan CoA (Certificate of Analysis) is a formal document that attests to Trexan's compliance with Trexan specifications and serves as a tool for batch-level quality control.
Trexan CoA mostly includes findings from lab analyses of a specific batch. For each Trexan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trexan may be tested according to a variety of international standards, such as European Pharmacopoeia (Trexan EP), Trexan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trexan USP).